Semler Scientific
Semler Scientific, Inc. is a medical technology company based in San Jose, California, focused on developing, manufacturing, and marketing proprietary products designed to assist healthcare providers in evaluating and treating chronic diseases. Founded in 2007, the company offers innovative solutions such as QuantaFlo, a quick in-office blood flow test that enables healthcare providers to assess patients' vascular conditions effectively. Semler's products cater to a diverse range of medical professionals, including cardiologists, nephrologists, and primary care physicians, as well as healthcare insurance plans and integrated delivery networks. The company aims to enhance the clinical effectiveness and efficiency of healthcare delivery while ensuring that providers can fully capture reimbursement for their services. With a commitment to advancing medical risk assessment, Semler Scientific is recognized for its contributions to improving patient care in the United States.
Top Regions
Top Stages
2 past transactions
Monarch Medical Technologies
Debt Financing in 2022
Monarch Medical Technologies is a medical technology company that specializes in providing advanced computer-based solutions for healthcare institutions, focusing on glycemic management. Its flagship product, the EndoTool Glucose Management System, offers a technology-enabled approach to managing blood glucose levels, replacing traditional manual dosing methods with a user-friendly software application that integrates with major electronic medical record systems. This FDA-cleared system is designed to enhance patient-specific glycemic control across various patient populations, including those with complex conditions such as sepsis and diabetic ketoacidosis. Additionally, Monarch Medical Technologies offers EndoTool Analytics, a reporting tool that helps healthcare organizations identify and analyze performance trends related to glycemic control, clinician compliance, and areas for improvement. The company is based in the United States and also provides clinical consulting services to support its clients in achieving optimal glycemic management outcomes.
Synaps Dx
Corporate Round in 2022
Synaps Dx is a privately held company focused on the research, development, and commercialization of diagnostics for neurodegenerative disorders and conditions, including Alzheimer’s Disease.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.